Colinz Laboratories Limited (BOM:531210)
India flag India · Delayed Price · Currency is INR
82.94
+0.37 (0.45%)
At close: Jul 28, 2026

Colinz Laboratories Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
61.3661.3665.2870.371.5569.74
Revenue Growth
-6.00%-6.00%-7.14%-1.75%2.59%13.24%
Gross Profit
44.2644.2643.8745.8447.6146.01
Operating Income
2.512.513.644.135.043.85
Net Income
5.155.154.974.874.573.39
Earnings Per Share
2.042.041.971.931.820.74
EPS Growth
3.55%3.55%2.07%6.04%145.95%64.44%

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
85.2985.2955.57057.2952.06
Total Debt
3.93.96.415.72.734.85
Net Cash (Debt)
81.3981.3949.0964.354.5547.22
Net Cash Growth
65.79%65.79%-23.65%17.87%15.54%28.00%
Net Cash Per Share
32.2732.2719.4825.5021.7110.30

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
25.4125.41-14.5410.354.034.67
Capital Expenditures
---2.62---0.38
Free Cash Flow
25.4125.41-17.1610.354.034.3
Free Cash Flow Growth
---156.84%-6.21%-78.52%

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
72.13%72.13%67.21%65.21%66.54%65.97%
Operating Margin
4.09%4.09%5.58%5.87%7.04%5.52%
Pretax Margin
11.23%11.23%9.49%9.25%8.38%6.89%
Profit Margin
8.38%8.38%7.61%6.92%6.39%4.87%
FCF Margin
41.41%41.41%-26.28%14.72%5.63%6.16%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
40.6621.7936.7519.4334.9831.73
P/FCF Ratio
8.224.41-9.1439.7125.06
PS Ratio
3.411.832.801.352.241.54